Risk factors for chronic kidney disease in Urban Uyo, South-South, Nigeria.

The prevalence of chronic kidney disease (CKD) is increasing the world over, and it is now regarded as a public health problem. The prevalence of CKD in Nigeria remained largely unknown with hospital-based data of 2-8%. However, emerging community studies show a prevalence of 10-26.8%. This study was conducted during the 2013 world kidney day activities in Uyo, Akwa Ibom, State of Nigeria, with an estimated population of 554,906 people. Sensitizations of members of the public were ensured through the media. Trained nurses of the dialysis unit were recruited for the exercise. A well-structured questionnaire was used to collect demographic data and medical history. Subjects also had measurements of their blood pressure, random blood sugar, urinalysis, serum creatinine, and anthropometric data. Five hundred and two adults (70.6% females and 29.4% males) aged 18-78 years participated in the study. A family history of CKD was found in 4.3% of the study participants. The risk factors for CKD investigated in this population included hypertension, diabetes mellitus, obesity, proteinuria, and hematuria. The prevalence of hypertension in this sample was 30.16% [95% confidence interval (CI) 26.14-34.18%]. Only 12.58% (95% CI 9.54-15.61%) were aware of their hypertension status. There was an increasing trend in the proportion of individuals with hypertension in each higher 10 years age group (P = 0.03). The independent predictors of hypertension in this cohort were age and body mass index. The proportion of those with diabetes mellitus in the study population was 5.8% (95% CI 3.7-7.8%). Obesity was found in 31.8% individuals' proteinuria in 23.5% and hematuria in 3.0%. There is a high prevalence of risk factors for CKD in our population. Therefore, screening for early detection should be encouraged.

Assessment of dyslipidemia in pre-dialysis patients in south-west Nigeria.

BACKGROUND: Majority of chronic kidney disease (CKD) patients are more likely to die of cardiovascular complications before reaching end stage renal disease. The Kidney Disease Outcomes Quality Initiative (K/DOQI) recommends that all CKD patients should be evaluated for dyslipidemia and for treatment to reduce the risk of cardiovascular events. PATIENTS AND METHODS: A cross-sectional case control study to determine the frequency of occurrence of lipid abnormalities in patients with CKD and compare these abnormalities with that of normal controls. A total of 100 patients and 100 controls were recruited for the study. Demographic and clinical data were obtained using structured questionnaire. Weight, height and waist circumference, body mass index (BMI) and blood pressure were also obtained. Subjects had their fasting lipid profile and fasting plasma glucose assayed after overnight fast of 8-14 hours. Low-density lipoprotein (LDL) was obtained using Friedwald formula. RESULT: The study revealed that total cholesterol (TC) was elevated above normal levels in 44% of cases compared with 6% in controls (P < 0.001), with the mean (SD) value of 5.82 ± 3.28 mmol/l for cases compared with 3.9 ± 1.0 mmol/l (P < 0.001) in controls. Low density lipoprotein was elevated in 48% of cases compared with 14% in controls (P < 0.001), with the mean (SD) values of 4.15 ± 2.74 mmol/l and 2.57 ± 0.95 mmol/l for cases and controls, respectively, (P < 0.001). Triglyceride (TG) was elevated above normal level in 26% of cases compared with none in the controls (P < 0.001), with the mean (SD) values of 1.41 ± 1.10 mmol/l and 0.64 ± 0.24 mmol/l for cases and controls, respectively (P < 0.001). All Lipid fractions except HDL also correlated significantly with levels of proteinuria TC (r = 0.345, P = 0.001), TG (r = 0.268, P = 0.011) LDL (r = 0.366, P = 0.001). CONCLUSION: Dyslipidemia is common among patients with CKD. Regular evaluation of all CKD patients for dyslipidemia and treatment need be instituted.